The Future of Disease Detection

Liver Disease

Liver Disease

  • Breath testing for liver diseases provides a safe, non-invasive method of assessing liver function by continuously measuring the by-product of 13C- methacetin metabolism in the breath of test subjects.
  • The test also provides relatively accurate measure of fibrosis and inflammation levels.
  • Breath testing avoids traumatic liver biopsy and extensive blood tests.
  • In 2013, 29 million in EU and over 30 million in the USA have liver disease (1 in 10 Americans).

Purchase this image at http://www.stocksy.com/593252

“The new test could be used to assess prognosis from the earliest stages of liver disease to cirrhosis, to help doctors determine whether a cirrhotic patient has enough liver function to undergo a surgical procedure, to prioritize patients for liver transplantation, and perhaps to decide when patients need to start therapy for chronic viral hepatitis…”Gadi Lalazar, M.D., Hebrew University- Hadassah Medical Center, Jerusalem